|
1
|
Cheng H and Perez-Soler R: Leptomeningeal
metastases in non-small-cell lung cancer. Lancet Oncol. 19:e43–e55.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakasu Y, Deguchi S, Nakasu S, Yamazaki M,
Notsu A, Mitsuya K and Hayashi N: Diagnostic accuracy of
cerebrospinal fluid liquid biopsy and MRI for leptomeningeal
metastases in solid cancers: A systematic review and meta-analysis.
Neurooncol Adv. 5:vdad0022023.PubMed/NCBI
|
|
3
|
Li D, Song Z, Dong B, Song W, Cheng C,
Zhang Y and Zhang W: Advances in targeted therapy in non-small cell
lung cancer with actionable mutations and leptomeningeal
metastasis. J Clin Pharm Ther. 47:24–32. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Remon J, Le Rhun E and Besse B:
Leptomeningeal carcinomatosis in non-small cell lung cancer
patients: A continuing challenge in the personalized treatment era.
Cancer Treat Rev. 53:128–137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sforza V, Palumbo G, Cascetta P, Carillio
G, Manzo A, Montanino A, Sandomenico C, Costanzo R, Esposito G,
Laudato F, et al: BRAF inhibitors in non-small cell lung cancer.
Cancers (Basel). 14:48632022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fernandes MG, Costa J, Reis J, Jacob M,
Moura C, Machado J and Hespanhol V: OA08. 07 BRAF-V600E Advanced
lung adenocarcinoma with leptomeningeal (LM) disease treated with
vemurafenib. J Thor Oncol. 12:S274–S275. 2017. View Article : Google Scholar
|
|
7
|
Tabbò F, Pisano C, Mazieres J, Mezquita L,
Nadal E, Planchard D, Pradines A, Santamaria D, Swalduz A, Ambrogio
C, et al: How far we have come targeting BRAF-mutant non-small cell
lung cancer (NSCLC). Cancer Treat Rev. 103:1023352022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Le Rhun E, Preusser M, van den Bent M,
Andratschke N and Weller M: How we treat patients with
leptomeningeal metastases. ESMO Open. 4 (Suppl 2):e0005072019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pan W, Gu W, Nagpal S, Gephart MH and
Quake SR: Brain tumor mutations detected in cerebral spinal fluid.
Clin Chem. 61:514–522. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Springer S, Zhang M, McMahon KW,
Kinde I, Dobbyn L, Ptak J, Brem H, Chaichana K, Gallia GL, et al:
Detection of tumor-derived DNA in cerebrospinal fluid of patients
with primary tumors of the brain and spinal cord. Proc Natl Acad
Sci USA. 112:9704–9709. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Pan W, Connolly ID, Reddy S, Nagpal
S, Quake S and Gephart MH: Tumor DNA in cerebral spinal fluid
reflects clinical course in a patient with melanoma leptomeningeal
brain metastases. J Neurooncol. 128:93–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu J, Mao G, Li Y, Tao L, Wang W, Peng X,
Wang J, Li X, Luan X, Luo R, et al: Targeted deep sequencing helps
distinguish independent primary tumors from intrapulmonary
metastasis for lung cancer diagnosis. J Cancer Res Clin Oncol.
146:2359–2367. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen S, Zhou Y, Chen Y and Gu J: Fastp: An
ultra-fast all-in-one FASTQ preprocessor. Bioinformatics.
34:i884–i890. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li H and Durbin R: Fast and accurate
long-read alignment with Burrows-Wheeler transform. Bioinformatics.
26:589–595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen S, Zhou Y, Chen Y, Huang T, Liao W,
Xu Y, Li Z and Gu J: Gencore: An efficient tool to generate
consensus reads for error suppressing and duplicate removing of NGS
data. BMC Bioinformatics. 20 (Suppl 23):S6062019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li H, Handsaker B, Wysoker A, Fennell T,
Ruan J, Homer N, Marth G, Abecasis G and Durbin R; 1000 Genome
Project Data Processing Subgroup, : The Sequence Alignment/Map
format and SAMtools. Bioinformatics. 25:2078–2079. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Koboldt DC, Zhang Q, Larson DE, Shen D,
McLellan MD, Lin L, Miller CA, Mardis ER, Ding L and Wilson RK:
VarScan 2: Somatic mutation and copy number alteration discovery in
cancer by exome sequencing. Genome Res. 22:568–576. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lajous H, Lelièvre B, Vauléon E, Lecomte P
and Garcion E: Rethinking alkylating (−like) agents for solid tumor
management. Trends Pharmacol Sci. 40:342–357. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nguyen A, Nguyen A, Dada OT, Desai PD,
Ricci JC, Godbole NB, Pierre K and Lucke-Wold B: Leptomeningeal
metastasis: A review of the pathophysiology, diagnostic
methodology, and therapeutic landscape. Curr Oncol. 30:5906–5931.
2023. View Article : Google Scholar : PubMed/NCBI
|
